Biodegradable Piezoelectric Ultrasonic Transducer for BBB Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional piezoelectric materials used in medical implants, such as PZT and PVDF, are toxic and non-degradable, posing safety concerns and requiring invasive removal surgeries, which is problematic for repetitive treatments like chemotherapy and drug delivery across the blood-brain barrier.
Innovation Solution
A biodegradable piezoelectric nanofiber platform made from materials like PLLA, PCL, and biodegradable metals, which can be used to create sensitive force sensors and ultrasonic transducers that self-degrade after use, eliminating the need for invasive removal and reducing toxicity risks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional piezoelectric materials (PZT, PVDF) are used in implanted transducers, then the transducers can effectively generate ultrasonic waves to open the blood-brain barrier, but the materials are toxic and non-degradable requiring invasive removal surgery
Solution Approach 1:
The patent changes the material parameters from conventional non-degradable piezoelectric materials (PZT, PVDF) to biodegradable materials with controlled degradation rates. The piezoelectric material is engineered to maintain functional properties during the treatment period then safely degrade, transforming the material's temporal characteristics to resolve the contradiction between effectiveness and safety.
Solution Approach 2:
The patent employs composite material structures combining biodegradable piezoelectric materials with biocompatible matrices or coatings. This composite approach allows the transducer to maintain structural integrity and piezoelectric functionality during operation while the biodegradable components enable safe resorption, eliminating the need for surgical removal.
2Reliability
If external ultrasonic transducers are used to open the blood-brain barrier, then the treatment can be performed, but the human skull absorbs more than 90% of ultrasonic energy requiring large and bulky arrays
Solution Approach 1:
The patent extracts the ultrasonic transducer from the external domain and implants it directly into the brain tissue adjacent to the target area. This relocation eliminates the skull barrier that causes 90% energy absorption, allowing effective treatment with a small, lightweight device positioned where it can directly sonicate the blood-brain barrier without needing large external arrays.
Solution Approach 2:
The implanted transducer serves as an intermediary device that bridges the gap between external control and internal treatment. It receives minimal external signals or power while performing the intensive ultrasonic work locally within the brain, eliminating the need for large external transducer arrays that would be required to penetrate the skull.
3Productivity
If conventional piezoelectric transducers are implanted for repetitive chemotherapy treatments, then repetitive BBB opening is possible, but the toxic materials pose safety concerns for repeated implantations
Solution Approach 1:
The patent designs the implanted transducer as a temporary, biodegradable device intended for short-term use during the treatment course. The biodegradable piezoelectric material allows the transducer to be safely implanted, used for repetitive treatments, and then naturally resorbed by the body, enabling multiple treatment cycles without cumulative toxicity concerns from repeated surgical implants.
Solution Approach 2:
The patent employs biodegradable materials that are gradually discarded by the body's natural metabolic processes after serving their therapeutic purpose. The piezoelectric material and structural components are designed to degrade into biocompatible byproducts that are safely eliminated, allowing the system to be replaced for repetitive treatments without long-term toxic accumulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biodegradable platform enables safe, repetitive, and effective monitoring of physiological pressures and drug delivery across biological barriers without causing harm to surrounding tissues, and can replace non-degradable RF devices with wireless ultrasonic capabilities.
Implementation Method 1
Piezoelectric materials, a type of 'smart' material that generates electricity while deforming and vice versa
Implementation Method 2
implanted piezoelectric ultrasonic transducers to disrupt the blood-brain barrier (BBB) and facilitate the delivery of drugs into the brain
Implementation Method 3
ultrasound (US) or acoustic waves have been extensively studied and shown to be safe and the most effective tool
Data Source
AI summary
A biodegradable and biocompatible piezoelectric nanofiber platform for medical implant applications, including a highly sensitive, wireless, biodegradable force sensor for the monitoring of physiological pressures, and a biodegradable ultrasonic transducer for the delivery of therapeutics or pharmaceuticals across the blood-brain barrier.